Mass Spectrometry Services

Introduction: Complex matrix interference is one of the most common and underestimated obstacles in proteomics, especially in regulated and translational

Introduction: Rapid Bioanalytical Method Development has become a critical requirement in modern drug development, especially during Phase II studies where

Introduction: Bioanalytical stability testing represents one of the most critical quality control measures in pharmaceutical development. When plasma samples show

Introduction: AI in bioanalysis is no longer a futuristic concept—it’s the present reality transforming how bioanalytical laboratories operate, analyze data,

Introduction: Bioanalysis is the foundation that enables safe, effective, and regulatory-compliant development of Antibody-Drug Conjugates (ADCs). Antibody-Drug Conjugates combine the

Introduction When planning a bioanalytical study for drug development, one of the most frequently asked questions is: “How long will

Introduction Bioanalytical data integrity serves as the cornerstone of regulatory compliance in pharmaceutical development, and FDA inspections rigorously evaluate whether

Introduction Managing bioanalytical CRO projects requires a strategic approach that balances scientific rigor, regulatory compliance, and operational efficiency. In today’s

Introduction The decision between Bioanalytical CRO vs In-house labs is one of the most important strategic choices a biotech company